Next Article in Journal
Positive Outcomes of Supplementation with Lecithin-Based Delivery Formulation of Curcuma longa and Boswellia serrata in IBS Subjects with Small Bowel Dysbiosis
Next Article in Special Issue
Drug-Induced Complete Atrioventricular Block in an Elderly Patient: A Case Report Highlighting Digoxin-Beta Blocker Interactions and a Paradoxical State
Previous Article in Journal
Genetic Insights on Meropenem Resistance Concerning Klebsiella pneumoniae Clinical Isolates
Previous Article in Special Issue
Regular Physical Activity Seems to Eliminate Lower Limb Perfusion Asymmetries in Sedentary Non-Healthy Older Individuals
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Astaxanthin Protects Against H2O2- and Doxorubicin-Induced Cardiotoxicity in H9c2 Rat Myocardial Cells

Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290 Pushchino, Russia
*
Author to whom correspondence should be addressed.
Life 2024, 14(11), 1409; https://doi.org/10.3390/life14111409
Submission received: 20 September 2024 / Revised: 28 October 2024 / Accepted: 30 October 2024 / Published: 1 November 2024

Abstract

:
Astaxanthin (AST) is a carotenoid that has positive effects on various organs and tissues. It also exhibits a cardioprotective action. In this study, the influence of AST on the survival of H9c2 cardiomyocytes under hydrogen peroxide (H2O2)- and doxorubicin (DOX)-induced cardiotoxicity was investigated. Under these conditions, the content of cytosolic Ca2+ was measured, and changes in the area of the mitochondrial mass, as well as in the content of the voltage-dependent anion channel 1 (VDAC1), the autophagy marker LC3A/B, and the pro-apoptotic transcription factor homologous protein (CHOP), were determined. It was found that AST removed the cytotoxic effect of H2O2 and DOX, while cell survival increased, and the mitochondrial mass did not differ from the control. At the same time, a decrease in the content of cytosolic Ca2+ and the restoration of the VDAC1 level to values close to the control were observed. The restoration of the CHOP level suggests a reduction in endoplasmic reticulum (ER) stress in cells. The results allow us to consider AST as a potential agent in the prevention and/or treatment of cardiac diseases associated with oxidative stress.

1. Introduction

Astaxanthin (3,3′-dihydroxy-β,β′-carotene-4,4′-dione, AST) belongs to a broad class of chemical compounds known as terpenes and is a xanthophyll because it has two extra oxygen atoms on each of its six-membered rings, differing from beta-carotene [1]. AST has beneficial properties, such as antioxidant, anti-aging, anti-inflammatory, antihypertensive and anti-cancer properties, which have expanded its use as a pharmaceutical, a cosmetic, a functional food, etc. [2,3]. In addition, AST has also been shown to have cardioprotective properties, and the AST diet is able to reduce the risk of cardiovascular disease [4].
For normal cell functioning, it is important to retain the structural and functional integrity of mitochondria, since mitochondria play an important role in energy metabolism, as well as in maintaining the redox state of cells and regulating the apoptosis. Mitochondria are one of the sources of ROS [5]. ROS play physiological and pathophysiological roles in biology and are closely related to redox signaling, but in some situations they can cause oxidative damage [6]. Mitochondrial dysfunction contributes to the development of oxidative stress, which can lead to various cell disorders and ultimately to cell death [7]. Recently, we have shown that AST improves the structure of cardiac tissue, as well as the functional state of rat heart mitochondria in isoproterenol-induced mitochondrial dysfunction [8,9].
It is known that the voltage-dependent anion channel 1 (VDAC1) is the protein localized in the outer membrane of mitochondria and plays a key role in mitochondrial function. VDAC1 mediates the fluxes of ions, nucleotides, and other metabolites across the outer mitochondrial membrane and controls metabolic and energetic crosstalk between mitochondria and the rest of the cell [10]. The role of VDAC1 in the pathogenesis of cardiac abnormalities is being studied intensively, and the results obtained indicate that VDAC1 may play a key role in cardiac pathology [11]. Moreover, it was reported that oxidative stress-induced injury of H9c2 myoblasts results in increased VDAC1 expression and oligomerization [12,13]. VDAC1 is involved in the transfer of Ca2+ from the endoplasmic reticulum (ER) to mitochondria [14]. In patients with hypertrophic cardiomyopathy, increased transcription levels of various genes including the VDAC1 gene were observed in septic tissue [15].
It is known that the endoplasmic/sarcoplasmic reticulum (ER/SR) is involved in the accumulation of Ca2+. A decrease in Ca2+ content in the cell can result in the disruption of the SR lumen, which ultimately leads to ER stress [16,17]. It is believed that the long-term ER stress activates a signaling pathway that induces transcription factors associated with apoptosis. One such factor is the C/EBP homologous protein (CHOP), which is activated in the PERK-ATF4-CHOP signaling pathway [18].
The goal of the present study was to assess the protective effects of AST against H2O2- and doxorubicin (DOX)-induced cardiotoxicity in H9c2 rat cardiomyocytes. H2O2 and DOX are potent oxidants that promote oxidative stress and cause oxidative damage to cardiomyocytes [19,20]. Therefore, these compounds are used to induce cytotoxic effects in healthy cells. We investigated the effect of AST on the mitochondrial mass, the cytosolic Ca2+ content, and the content of VDAC1 and CHOP while the cytotoxic effect of H2O2 and DOX were present. The results showed that AST attenuated H2O2- and DOX-induced cardiotoxicity in H9c2 cardiomyocytes, suggesting its potential use in the prevention and treatment of cardiovascular diseases.

2. Materials and Methods

2.1. Cell Culture and Treatment

The H9c2 cell line, derived from the rat myocardium, was purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA). Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS, Thermo Fisher Scientific, Waltham, MA, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin (Sigma, St. Louis, MO, USA) in a humidified incubator with 95% air and 5% CO2 at 37 °C. To induce cardiotoxicity in cardiomyocytes, H2O2 (Sigma, Louis, MO, USA) was used at different concentrations: 0, 25, 50, and 100 μmol/L. The rate of the inhibition of cell proliferation was 50%, depending on the concentration in subsequent experiments. H9c2 cells (2.5 × 103 cells/well) seeded in a 96-well plate were treated with H2O2 (0–100 μM) or DOX (0–100 μM) for 24 h, or cells were treated with AST (5, 10, 15, 20 μM) for 4 and 6 h.

2.2. Cell Viability Analysis

Cell viability was assessed using the resazurin recovery method. Cells at a density of 2.5 × 103 cells/well were seeded in a 96-well plate. After 24 h, the cells were treated with AST (Macklin Inc., Shanghai, China) (5–20 µM), H2O2 (0–100 μM), and DOX (0–100 μM). Twenty four hours after the addition of the test substances, resazurin (Sigma-Aldrich, USA) was added to each well at a final concentration of 100 µg/mL, and cells were incubated for 4 h under CO2 incubator conditions. Fluorescence analysis was performed on an Infinite F200 microplate reader (Tecan, Männedorf, Switzerland) at an excitation wavelength of 535 nm and an emission wavelength of 595 nm. The data are given as the percentage of the control (untreated cells). The number of dead cells after incubation with AST (10 μM), H2O2 (100 μM), and DOX (100 μM) was determined using a commercial Cytotoxicity Detection Kit (LDH) (Roche Diagnostics GmbH Waldhof, Mannheim, Germany) according to the manufacturer’s recommendations. Optical density was measured at 490 nm using an iMARK plate reader (Bio-Rad, Hercules, CA, USA). Cells treated with 1% Triton X-100 (Helicon, Moscow, Russia) were used as a control. The data are presented as percentage.

2.3. Confocal Microscopy

For confocal microscopy experiments, H9c2 cells were seeded in 35 mm Petri dishes (15,000 cells/cm2) and treated with 10 μM AST, 100 μM H2O2, or 100 μM DOX for 1 h. In a combined study of AST and H2O2 or AST and Dox, pre-incubation with AST was performed for 4 and 6 h, respectively. After the incubation, the cells were washed three times with 2 mL of HBSS and incubated in 2 mL of HBSS supplemented with 1 μg/mL Bisbenzimide Hoechst 33342 (H33342, Sigma-Aldrich, St. Louis, MO, USA) and 150 nM MitoTracker Green FM (Cell Signaling, Danvers, MA, USA) at 37 °C for 30 min in a thermostat without CO2. After staining, the cells were washed 3 times with HBSS buffer. Fluorescent images of cells were obtained using a fluorescence scanning confocal microscope Leica TCS SP-5 DM6000 CS (Leica Microsystems, Wetzlar, Germany).

2.4. Analysis of Cytosolic Ca2+ Content

The cytosolic Ca2+ content was changed using the fluorescent dye Fluo-4 AM (Sigma-Aldrich, USA). To do this, cells were seeded onto a 96-well plate at a concentration of 1 × 106 cells/well and incubated with the test drugs for 24 h. Next, the cells were pelleted at 250× g for 5 min and t = 25 °C, washed once in PBS, and a cell suspension of 1 × 106 cells/mL was prepared in PBS. Cells were stained by adding 2 μM Fluo-4 AM to the suspension and were subsequently incubated for 30 min in a CO2 incubator. After staining, cells were washed once in PBS. The change in cytosolic Ca2+ content was carried out on an Infinite F200 PRO (Tecan, Männedorf, Switzerland) at an excitation wavelength of 494 nm and an emission wavelength of 516 nm.

2.5. Western Blot Assay

H9c2 cells were incubated with AST (1000 µM) and H2O2. After 24 h, cells were washed twice with ice-cold PBS and centrifuged at 1500× g for 3 min at room temperature. The precipitate was dissolved in lysis buffer with the addition of protein kinase/phosphatase inhibitors. After rotating the samples at 4 °C for two hours, the samples were centrifuged at 13,000× g for 10 min. The resulting supernatants were measured for protein concentrations by the Bradford method and dissolved in Laemmli sample buffer (Bio-Rad, Hercules, CA, USA), heated to 95 °C for 5 min. The resulting lysates (20 μg per lane) were separated by 12.5% SDS-PAGE. Proteins were then transferred from the gel to a nitrocellulose membrane (0.2 μm) using Western blotting (Bio-Rad. Hercules, CA, USA). The membrane was blocked in Roti-block solution (Carl Roth GmbH + Co., Karlsruhe, Germany) at room temperature for one hour. The membrane was then incubated with primary antibodies as described in the instructions. Antibodies to VDAC1 (Abcam, Cambridge, UK), LC3A/B (Cell signaling, Danvers, MA, USA), and CHOP (FineTest, Wuhan, China) were used. GAPDH (Santa Cruz, Dallas, TX, USA) was used as a loading control.

2.6. Statistical Analysis

Statistical analysis was performed using one-way ANOVA and appropriate post hoc analysis (Student–Newman–Keuls). Differences were considered significant at p < 0.05.

3. Results

3.1. The Cytotoxic Effect of AST, H2O2, and DOX on the Survival of H9c2 Cardiomyocytes

The possible protective effect of AST was identified using models in which the damage to and the death of H9c2 rat cardiomyocytes were achieved using cytotoxicity inducers, such as H2O2 [21] and DOX [22]. Previously, we observed that, when incubating cells with different concentrations of AST together with H2O2 or DOX in the range from 5 to 100 μM, only 5 and 10 μM AST showed a protective effect (Supplementary Figure S1).
The combined effect of AST, H2O2, and DOX on the viability of H9c2 cells was assessed for one, four, and six hours of incubation, since the change in cell viability depended not only on the concentration of the used substances but also on the time of incubation with AST.
Here, we show the combined effect of 10 μM AST with 100 μM H2O2 or 100 μM DOX (Figure 1). Cardiomyocytes in an amount of 2.5 × 103 were incubated with AST for 1, 4, and 6 h, after which cytotoxicity inducers were added and cell viability was measured. When incubated with AST for 1, 4, and 6 h, cell viability was not different from the control. After the addition of H2O2 (100 μM) to cells, the viability decreased by 66.6 ± 5% relative to the control.
The combined effect of AST and H2O2 (1 h incubation with AST) decreased cell viability by 50% compared to the control and increased it by 37% relative to the effect of H2O2 alone. Four-hour incubation with AST followed by the addition of H2O2 resulted in an increase in cell viability by 2.5 times compared to the effect of H2O2 alone and did not differ from the control.
The incubation of cells with AST, regardless of the incubation time, did not reveal a significant effect; the viability did not differ from the control. Although cell viability was reduced by 65% with H2O2 (100 μM), the incubation of cells with 10 μM AST for 4 h followed by the addition of H2O2 (100 μM) was not different from the control. After six hours of incubation with AST, the addition of 100 μM H2O2 resulted in a 10% reduction in cell viability.
Figure 1b shows a change in cell viability after incubation with AST for six hours followed by the addition of DOX. As can be seen, after one, four, and six hours of incubation with AST, cell viability did not differ from the control. The addition of DOX to the cells decreased the viability by approximately 65–70% compared to the control. The addition of DOX to AST-incubated cells resulted in a decrease in cell viability by 65% (after 1 h incubation with AST), 50% (after 4 h incubation with AST) and 30% (after 6 h incubation with AST) compared to the control.
Thus, the protective effect of AST was more significant at concentrations of 10 μM AST with 100 μM H2O2 when cells were incubated with AST for four hours and 10 μM AST with 100 μM DOX when cells were incubated with AST for six hours.
Next, we investigated the effect of AST and its combined action with cytotoxicity inducers on the survival/death of H9c2 cells (Figure 2). Triton X-100 (1%) was considered a control and implied 100% cell death.
Figure 2a shows changes in the number of dead cells in the presence of AST, H2O2, and the combined effect of AST and H2O2. It is seen that the number of dead cells in the control (untreated cells) did not exceed approximately 2%. When cells were incubated for 4 h with 10 μM AST, the number of dead cells, as in the control, did not exceed 2%, whereas in the presence of H2O2 (100 μM), the number of dead cells reached 65%. With the combined effect of AST and H2O2, the number of dead cells did not exceed 7%. Figure 2b shows changes in the number of dead cells in the presence of AST and DOX, as well as the combined effect of AST and DOX. In the control (untreated cells) and during the 6 h incubation of cells with 10 μM AST, the number of dead cells did not exceed approximately 2%. In the presence of DOX (100 μM), the number of dead cells reached 57%. The combined action of AST and DOX resulted in a decrease in the number of dead cells relative to the action of DOX alone and was approximately 32%.
Next, we studied the effect of AST (10 μM), H2O2 (100 μM), and DOX (100 μM) on the morphological characteristics of mitochondria in a monolayer of H9c2 cardiomyocytes. We noticed that, after the addition of H2O2 (Figure 3) or DOX (Figure 4) to the cells, mitochondria concentrated around the nucleus in the cell, and their numbers decreased compared to the control. Therefore, we measured the area of mitochondria in a monolayer of cells under our experimental conditions. To do this, an equal number of cells was checked, and the area of mitochondria in each cell was calculated using the ImageJ software (https://imagej.nih.gov/ij/ (accessed on 12 June 2024)).

3.2. The Effect of AST, H2O2, and DOX on the Change in Mitochondrial Mass in H9c2 Cardiomyocytes

Figure 3a depicts the data of confocal fluorescent microscopy where the mitochondrial mass is stained with MitoTracker Green FM, and cell nuclei are stained blue (Hoechst 33342) in the presence of AST, H2O2, and of AST in combination with H2O2. Figure 3b shows changes in the area of mitochondria in the cell. Incubation of cells with AST for 4 h did not change the mitochondrial mass, while hydrogen peroxide significantly reduced it by 70%. When AST and H2O2 were used together, the mitochondrial area did not differ from the control. With doxorubicin used as an inducer of cytotoxicity, almost similar results were obtained (Figure 4).
Figure 4a shows the data for confocal microscopy, and Figure 4b represents the area of mitochondria in cells. The incubation with AST for 6 h did not change the area of mitochondria relative to the control. The addition of DOX decreased the mitochondrial mass by 50%. With the combined action of AST and DOX, the mitochondrial area approached the control values.

3.3. Effect of AST, H2O2, and DOX on the Content of Cytosolic Ca2+ in H9c2 Cardiomyocytes

It is known that Ca2+ is an important secondary messenger, which is involved in many cellular processes, such as protein synthesis and secretion, gene expression, cell cycle progression, metabolism, apoptosis, and others [23].
Therefore, at the next stage, the effect of AST on the level of cytosolic Ca2+ in H9c2 cardiomyocytes was studied while cytotoxicity caused by H2O2 and DOX was experienced (Figure 5). Figure 5a,b shows changes in the content of cytosolic Ca2+ under the combined influence of AST with H2O2 and AST with DOX based on the changes in fluorescence intensity with the use of Fluo 4 fluorescent dye. As seen from Figure 5a, the content of cytosolic Ca2+ increased at a concentration of H2O2 of 25 μM by 40% and at concentrations of 50 and 100 μM by two times compared to the control. The incubation of cells with 10 μM AST for 4 h followed by the addition of H2O2 reduced the content of cytosolic Ca2+ by 20% compared to 25 μM H2O2, by 35% compared to 50 μM H2O2, and by 20% with 100 μM H2O2.
With DOX used as an inducer of cell cytotoxicity, similar results were obtained. The content of cytosolic Ca2+ increased in the range of 25–100 µM DOX from 35 to 90%, respectively (Figure 5b). When cells were treated with 10 μM AST, the content of cytosolic Ca2+ decreased by 40% compared to 25 μM DOX, by 35% compared to 50 μM DOX, and by 40% compared to 100 μM DOX. Thus, AST reduced the content of cytosolic Ca2+ in H9c2 cardiomyocytes during H2O2- and DOX-induced cytotoxicity. At the same time, it exhibited a protective effect.

3.4. Effect of AST, H2O2, and DOX on the Level of VDAC1 and CHOP in H9c2 Cardiomyocytes

It is known that there are three isoforms of the voltage dependent anion channel (VDAC); however, VDAC1 is the most abundant isoform in mitochondria. It has been shown that VDAC1 levels can increase under conditions of oxidative stress. At the next stage, we examined changes in the content of VDAC1 and CHOP under our experimental conditions (Figure 6).
Figure 6 shows Western blot stained with antibodies to VDAC1 and CHOP. The antibody to GAPDH was used as a loading control. AST (4 h) reduced the level of VDAC1 by 50%, while H2O2 increased it almost three times compared to the control (Figure 6a). With the combined effect of AST and H2O2, the content of VDAC1 increased by 1.5 times compared to the control but decreased by 1.5 times compared to the action of H2O2 alone. The content of VDAC1 in cells incubated with AST for 6 h decreased by 50% relative to the control. The addition of DOX to cells reduced the level of VDAC1 by 20% relative to the control, but the combined effect of AST and DOX led to a decrease in the level of VDAC1 by 45% in comparison with the control. On the other hand, DOX increased the content of VDAC1 by 40% relative to the effect of AST (6 h) alone; however, the combined effect of AST and DOX resulted in a decrease in the VDAC1 level compared to the effect of DOX alone.
Figure 6b (upper part) shows Western blot stained with the antibody to CHOP, lower part represents quantitative changes in immunostaining normalized to GAPDH. A 4 h incubation with AST did not change the content of CHOP, while H2O2 reduced it by 45% compared to the control. When AST and H2O2 were used together, the level of CHOP decreased by 30% relative to the control but increased by 15% relative to the effect of H2O2 alone. A 6 h incubation with AST reduced the content of CHOP by 20% and with DOX by 40% compared to the control. The combined effect of AST and DOX reduced the level of CHOP by 25% relative to the control but increased it by 15% relative to the effect of DOX alone.

4. Discussion

The growing incidence of cardiovascular diseases in developing countries is one of the most pressing health problems today. Myocardial infarction is the most common form of coronary heart disease and a cause of premature death [24]. It is known that mitochondria are involved in the etiology of various diseases, such as neurodegenerative and cardiovascular diseases, diabetes, various forms of liver and musculoskeletal diseases, sepsis, and psychiatric disorders [25]. Moreover, oxidative stress and the deterioration of Ca2+ homeostasis are considered important factors in mitochondrial dysfunctions, as they can lead to cell death [26]. Among effective substances that can be used as protection against mitochondrial dysfunction is the dietary antioxidant astaxanthin. In the present study, we studied the effect of AST on the viability of H9c2 cardiomyocytes after the addition of cytotoxicity inducers such as H2O2 and DOX. We studied changes in the mitochondrial mass, the cytosolic Ca2+ content, as well as in the content of VDAC1 and CHOP under these conditions. Analyzing the effect of different AST concentrations on cell survival, we came to the conclusion that lower AST concentrations of 5 and 10 μM with the addition of high concentrations of cytotoxicity inducers (H2O2 and DOX) were more effective (Supplementary File S1). In the present study, 10 μM AST was selected as the most suitable for the protective effect of AST. At this concentration of AST, cell viability increased despite the cytotoxic effects of H2O2 and DOX. The protective properties of AST were more pronounced in H2O2-induced cytotoxicity than in DOX-induced cytotoxicity, probably because the mechanisms of action of H2O2 and DOX on cells differ. The mechanism of the cytotoxic action of DOX is mediated not only by oxidative stress, as in the case of H2O2, but it is also associated with the suppression of DNA synthesis and translation due to DNA intercalation, as well as the formation of double-strand breaks due to the inhibition of DNA topoisomerase II activity [27]. Interestingly, AST has the opposite effect on cancer cells. It has been shown that astaxanthin can suppress cancer proliferation in human non-small cell lung cancer, bronchioloalveolar carcinoma (A549), and squamous cell carcinoma (H1703) cells by reducing the colony formation ability of the cells at a concentration of 20 μM [28]. AST enhanced tumor cell sensitization to chemotherapy and suppressed its side effects. In this context, AST can be considered as a potential candidate for use in combination therapy in the fight against cancer in patients with developing resistance to traditional therapy [29]. The opposing effects of AST in healthy and cancer cells suggest the presence of different targets and mechanisms of its action.
It is believed that the balance between the rate of mitochondrial biogenesis and degradation may determine the number of mitochondria in any cell [30]. Here, the H9c2 cell line was grown under different experimental conditions. Mitochondria were tagged with MitoTracker Green FM and quantified using the ImageJ software (https://imagej.nih.gov/ij/ (accessed on 12 June 2024)). Our results demonstrate that incubation of cells with AST for 4 and 6 h did not change the number of mitochondria, while the addition of H2O2 and DOX led to a significant decrease in the number of mitochondria compared to the control. Moreover, we noticed that mitochondria under the conditions of cytotoxic action of H2O2 and DOX were shorter than in the control and during the incubation of cells with AST. This indicates the initiation of mitochondrial fragmentation with the addition of cytotoxicity inducers. Cun-dong Fan et al. showed that AST blocked a homocysteine-induced drop in the mitochondrial membrane potential (ΔΨm) and mitochondrial fragmentation in H9c2 cells [31]. We previously showed that H2O2 and DOX decreased the mitochondrial potential (ΔΨm) [32], while AST restored it. Recently, we examined changes in the expression of prohibitin (PHB) under similar conditions and found that the protein content was reduced in the presence of H2O2 and DOX [32]. It is known that PHB depletion severely affects mitochondrial morphology in C. elegans body wall muscle cells [31]. In normal muscle cells, mitochondria appeared tubular, elongated, and well structured. With PHB loss, mitochondria showed up fragmented and disorganized [31]. Similarly, decreased PHB expression resulted in the accumulation of fragmented mitochondria in MEF and HeLa cells [33,34]. According to our results, it is logical to assume that in the presence of cytotoxicity inducers, a decrease in the PHB content could lead to a reduction in mitochondrial mass and their fragmentation. Increasing levels of PHB resulted in restoration of mitochondrial mass to the control values.
VDAC1, located on the outer mitochondrial membrane, is known to be an important protein for mitochondrial function. It mediates the transport of ions, nucleotides, and other metabolites across the outer mitochondrial membrane and the energetic crosstalk between mitochondria and the cell and is also involved in the release of apoptogenic proteins that initiate apoptotic cell death [10,30,35]. It has been shown that VDAC1 expression levels were increased and oligomerization occurred in H9c2 myoblasts under oxidative stress [12,13]. Moreover, VDAC1 was found to be involved in the detrimental Ca2+ transfer from the endoplasmic reticulum (ER) to mitochondria [14]. VDAC1 overexpression is associated with myocardial abnormalities in common pathological conditions. Other researchers have shown that increased levels of VDAC1 expression in a rat model of cardiac hypertrophy were induced by renal artery ligation [36]. According to our studies, H2O2 and DOX caused a cytotoxic effect in H9c2 cardiomyocytes and increased the content of cytosolic Ca2+; at the same time, the overexpression of VDAC1 was observed in cells. However, incubation with AST led to a decrease in Ca2+ in the cytosol and a decrease in the level of VDAC1 expression. The more pronounced expression of VDAC1 during H2O2-induced cytotoxicity may be explained as occurring through mechanisms different from those of DOX.
The endoplasmic/sarcoplasmic reticulum (ER/SR) is an intracellular organelle involved in Ca2+ accumulation and is thought to be sensitive to changes in Ca2+ homeostasis. Depletion of Ca2+ from the lumen of the SR can impair its function, which can result in stress of the ER. ER stress results in organelle damage and dysfunction, leading to apoptosis [16,17]. In addition, Bcl-2 family proteins, together with the transcription factor CHOP, are involved in the regulation that mediates ER stress-induced apoptosis [16]. Moreover, it was shown that, in neonatal rat cardiomyocytes, upon initiation of oxidative stress by H2O2, there was a decrease in CHOP expression [37]. In our experiments, we observed that, with decreased cell viability in the presence of H2O2 and DOX, the level of CHOP decreased, while AST increased the viability of cardiomyocytes and increased CHOP expression. There is an interorganellar crosstalk between the ER and mitochondria, which plays a crucial role in various pathological processes, especially in Ca2+ homeostasis [38]. VDAC1 is involved in Ca2+ transport from the ER to mitochondria, while the ER (the major intracellular Ca2+ storage system) can transmit Ca2+ signals to mitochondria [39]. Multiple proteins are involved in the linkage of the ER and mitochondria. It has been reported that the ER inositol 1,4,5-triphosphate receptor (IP3R) associates with VDAC1 in the outer mitochondrial membrane, forming a pathway for Ca2+ transport [40], while under ER stress conditions, CHOP activates the IP3R-mediated release of endoplasmic reticulum Ca2+ into the cytosol [41,42]. It should be noted that, in ischemic disease of the heart, apoptosis of cardiomyocytes mechanically associated with ER stress and mitochondrial dysfunction can lead to the occurrence of myocardial infarction [43,44]. Reduced Ca2+ signaling may serve as a possible mechanism to prevent ER stress-mediated mitochondrial Ca2+ overload and mitochondrial membrane permeability impairment, ultimately protecting against the initiation of cell death. This section of the study requires further study in more detail.

5. Conclusions

As a result of the cytotoxic effect of H2O2 and DOX, cell survival decreased, while an increase in the cytosolic Ca2+ content and a dramatic increase in the expression of VDAC1 were observed. It should be noted that the number of mitochondria under these conditions decreased and they were fragmented. The mitochondria of cardiomyocytes were more sensitive to Ca2+, as indicated by the effects of its increase in the cytosol. At the same time, the content of the transcription factor CHOP decreased. We have previously found that under these conditions, a decrease in the membrane potential of mitochondria occurs. Damaged mitochondria with low potential accumulated in cells and were not removed by autophagy. The pre-incubation of cells with AST, despite the addition of cytotoxicity inducers to the cells, resulted in a decrease in the cytosolic Ca2+ content, and mitochondria were more resistant to Ca2+. This resulted in the restoration of VDAC1 levels. In addition, the number of mitochondria did not differ from the control. AST effectively improved cell survival and reduced the cytosolic Ca2+ overload, possibly through the disruption of the CHOP-VDAC1 signaling pathway, thereby protecting mitochondrial morphology. According to our findings, we suggest that AST involves the mitochondrial pathway as a signaling pathway, through which AST exerts a protective effect on cardiomyocytes.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/life14111409/s1. Figure S1: The dependence of the viability of H9c2 cardiomyocyte cells on the concentration of AST, H2O2, DOX and on the time of incubation with AST.

Author Contributions

Conceptualization, O.K. and R.K.; methodology, M.K. and L.S.; software, Y.B.; validation, M.K., O.K., Y.B., and R.K.; formal analysis, Y.B.; resources, O.K.; data curation, L.S.; writing—original draft preparation, O.K.; writing—review and editing, R.K.; visualization, Y.B.; supervision, O.K.; project administration, R.K.; funding acquisition O.K. All authors have read and agreed to the published version of the manuscript.

Funding

The work was carried out with the financial support of the Russian Science Foundation (No. 24-25-00129).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are contained within this article.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Choi, S.; Koo, S. Efficient syntheses of the keto-carotenoids canthaxanthin, astaxanthin, and astacene. J. Org. Chem. 2005, 70, 3328–3331. [Google Scholar] [CrossRef] [PubMed]
  2. Gong, M.; Bassi, A. Carotenoids from microalgae: A review of recent developments. Biotechnol. Adv. 2016, 34, 1396–1412. [Google Scholar] [CrossRef] [PubMed]
  3. Hussein, G.; Sankawa, U.; Goto, H.; Matsumoto, K.; Watanabe, H. Astaxanthin, a carotenoid with potential in human health and nutrition. J. Nat. Prod. 2006, 69, 443–449. [Google Scholar] [CrossRef] [PubMed]
  4. Abdelzaher, L.A.; Imaizumi, T.; Suzuki, T.; Tomita, K.; Takashina, M.; Hattori, Y. Astaxanthin alleviates oxidative stress insults-related derangements in human vascular endothelial cells exposed to glucose fluctuations. Life Sci. 2016, 150, 24–31. [Google Scholar] [CrossRef] [PubMed]
  5. Murphy, M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417, 1–13. [Google Scholar] [CrossRef]
  6. Murphy, M.P.; Bayir, H.; Belousov, V.; Chang, C.J.; Davies, K.J.A.; Davies, M.J.; Dick, T.P.; Finkel, T.; Forman, H.J.; Janssen-Heininger, Y.; et al. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nat. Metab. 2022, 4, 651–662. [Google Scholar] [CrossRef]
  7. Kim, S.H.; Kim, H. Inhibitory effect of astaxanthin on oxidative stress-induced mitochondrial dysfunction-a mini-review. Nutrients 2018, 10, 1137. [Google Scholar] [CrossRef]
  8. Krestinin, R.; Baburina, Y.; Odinokova, I.; Kruglov, A.; Fadeeva, I.; Zvyagina, A.; Sotnikova, L.; Krestinina, O. Isoproterenol-induced permeability transition pore-related dysfunction of heart mitochondria is attenuated by astaxanthin. Biomedicines 2020, 8, 437. [Google Scholar] [CrossRef]
  9. Krestinina, O.; Baburina, Y.; Krestinin, R.; Odinokova, I.; Fadeeva, I.; Sotnikova, L. Astaxanthin prevents mitochondrial impairment induced by isoproterenol in isolated rat heart mitochondria. Antioxidants 2020, 9, 262. [Google Scholar] [CrossRef]
  10. Shoshan-Barmatz, V.; De, S.; Meir, A. The mitochondrial voltage-dependent anion channel 1, Ca2+ transport, apoptosis, and their regulation. Front. Oncol. 2017, 7, 60. [Google Scholar] [CrossRef]
  11. Schwertz, H.; Carter, J.M.; Abdudureheman, M.; Russ, M.; Buerke, U.; Schlitt, A.; Muller-Werdan, U.; Prondzinsky, R.; Werdan, K.; Buerke, M. Myocardial ischemia/reperfusion causes vdac phosphorylation which is reduced by cardioprotection with a p38 map kinase inhibitor. Proteomics 2007, 7, 4579–4588. [Google Scholar] [CrossRef] [PubMed]
  12. Jiang, L.; Wang, H.; Chen, G.; Feng, Y.; Zou, J.; Liu, M.; Liu, K.; Wang, N.; Zhang, H.; Wang, K.; et al. Wdr26/mip2 interacts with vdac1 and regulates vdac1 expression levels in h9c2 cells. Free Radic. Biol. Med. 2018, 117, 58–65. [Google Scholar] [CrossRef] [PubMed]
  13. Yang, M.; Xu, Y.; Heisner, J.S.; Sun, J.; Stowe, D.F.; Kwok, W.M.; Camara, A.K.S. Peroxynitrite nitrates adenine nucleotide translocase and voltage-dependent anion channel 1 and alters their interactions and association with hexokinase ii in mitochondria. Mitochondrion 2019, 46, 380–392. [Google Scholar] [CrossRef] [PubMed]
  14. Paillard, M.; Tubbs, E.; Thiebaut, P.A.; Gomez, L.; Fauconnier, J.; Da Silva, C.C.; Teixeira, G.; Mewton, N.; Belaidi, E.; Durand, A.; et al. Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia-reoxygenation injury. Circulation 2013, 128, 1555–1565. [Google Scholar] [CrossRef] [PubMed]
  15. Lim, D.S.; Roberts, R.; Marian, A.J. Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: Insight into the pathogenesis of phenotypes. J. Am. Coll. Cardiol. 2001, 38, 1175–1180. [Google Scholar] [CrossRef]
  16. Kaufman, R.J. Orchestrating the unfolded protein response in health and disease. J. Clin. Investig. 2002, 110, 1389–1398. [Google Scholar] [CrossRef]
  17. Schroder, M.; Kaufman, R.J. The mammalian unfolded protein response. Annu. Rev. Biochem. 2005, 74, 739–789. [Google Scholar] [CrossRef]
  18. Nishitoh, H. Chop is a multifunctional transcription factor in the er stress response. J. Biochem. 2012, 151, 217–219. [Google Scholar] [CrossRef]
  19. Jungsuwadee, P. Doxorubicin-induced cardiomyopathy: An update beyond oxidative stress and myocar-dial cell death. Cardiovasc. Regen. Med. 2016, 3, e1127. [Google Scholar]
  20. Janero, D.R.; Hreniuk, D.; Sharif, H.M. Hydrogen peroxide-induced oxidative stress to the mammalian heart-muscle cell (cardiomyocyte): Lethal peroxidative membrane injury. J. Cell Physiol. 1991, 149, 347–364. [Google Scholar] [CrossRef]
  21. Chen, Q.M.; Tu, V.C.; Wu, Y.; Bahl, J.J. Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes. Arch. Biochem. Biophys. 2000, 373, 242–248. [Google Scholar] [CrossRef] [PubMed]
  22. Octavia, Y.; Tocchetti, C.G.; Gabrielson, K.L.; Janssens, S.; Crijns, H.J.; Moens, A.L. Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. J. Mol. Cell Cardiol. 2012, 52, 1213–1225. [Google Scholar] [CrossRef] [PubMed]
  23. Coe, H.; Michalak, M. Calcium binding chaperones of the endoplasmic reticulum. Gen. Physiol. Biophys. 2009, 28, F96–F103. [Google Scholar] [PubMed]
  24. Kayikcioglu, M.; Ozkan, H.S.; Yagmur, B. Premature myocardial infarction: A rising threat. Balkan Med. J. 2022, 39, 83–95. [Google Scholar] [CrossRef] [PubMed]
  25. Rezin, G.T.; Amboni, G.; Zugno, A.I.; Quevedo, J.; Streck, E.L. Mitochondrial dysfunction and psychiatric disorders. Neurochem. Res. 2009, 34, 1021–1029. [Google Scholar] [CrossRef]
  26. Bhatti, J.S.; Bhatti, G.K.; Reddy, P.H. Mitochondrial dysfunction and oxidative stress in metabolic disorders—A step towards mitochondria based therapeutic strategies. Biochim. Biophys. Acta Mol. Basis Dis. 2017, 1863, 1066–1077. [Google Scholar] [CrossRef]
  27. Thorn, C.F.; Oshiro, C.; Marsh, S.; Hernandez-Boussard, T.; McLeod, H.; Klein, T.E.; Altman, R.B. Doxorubicin pathways: Pharmacodynamics and adverse effects. Pharmacogenet Genom. 2011, 21, 440–446. [Google Scholar] [CrossRef]
  28. Ko, J.C.; Chen, J.C.; Wang, T.J.; Zheng, H.Y.; Chen, W.C.; Chang, P.Y.; Lin, Y.W. Astaxanthin down-regulates rad51 expression via inactivation of akt kinase to enhance mitomycin c-induced cytotoxicity in human non-small cell lung cancer cells. Biochem. Pharmacol. 2016, 105, 91–100. [Google Scholar] [CrossRef]
  29. Faraone, I.; Sinisgalli, C.; Ostuni, A.; Armentano, M.F.; Carmosino, M.; Milella, L.; Russo, D.; Labanca, F.; Khan, H. Astaxanthin anticancer effects are mediated through multiple molecular mechanisms: A systematic review. Pharmacol. Res. 2020, 155, 104689. [Google Scholar] [CrossRef]
  30. Robin, E.D.; Wong, R. Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells. J. Cell Physiol. 1988, 136, 507–513. [Google Scholar] [CrossRef]
  31. Fan, C.D.; Sun, J.Y.; Fu, X.T.; Hou, Y.J.; Li, Y.; Yang, M.F.; Fu, X.Y.; Sun, B.L. Astaxanthin attenuates homocysteine-induced cardiotoxicity in vitro and in vivo by inhibiting mitochondrial dysfunction and oxidative damage. Front. Physiol. 2017, 8, 1041. [Google Scholar] [CrossRef] [PubMed]
  32. Krestinin, R.; Kobyakova, M.; Baburina, Y.; Sotnikova, L.; Krestinina, O. Astaxanthin reduces h2o2– and doxorubicin-induced cardiotoxocity in h9c2 cardiomyocite cells. Biochem. Mosc. 2024, 89. in press. [Google Scholar]
  33. Kasashima, K.; Ohta, E.; Kagawa, Y.; Endo, H. Mitochondrial functions and estrogen receptor-dependent nuclear translocation of pleiotropic human prohibitin 2. J. Biol. Chem. 2006, 281, 36401–36410. [Google Scholar] [CrossRef] [PubMed]
  34. Merkwirth, C.; Dargazanli, S.; Tatsuta, T.; Geimer, S.; Lower, B.; Wunderlich, F.T.; von Kleist-Retzow, J.C.; Waisman, A.; Westermann, B.; Langer, T. Prohibitins control cell proliferation and apoptosis by regulating opa1-dependent cristae morphogenesis in mitochondria. Genes Dev. 2008, 22, 476–488. [Google Scholar] [CrossRef] [PubMed]
  35. Shoshan-Barmatz, V.; Ben-Hail, D. Vdac, a multi-functional mitochondrial protein as a pharmacological target. Mitochondrion 2012, 12, 24–34. [Google Scholar] [CrossRef]
  36. Mitra, A.; Basak, T.; Datta, K.; Naskar, S.; Sengupta, S.; Sarkar, S. Role of alpha-crystallin b as a regulatory switch in modulating cardiomyocyte apoptosis by mitochondria or endoplasmic reticulum during cardiac hypertrophy and myocardial infarction. Cell Death Dis. 2013, 4, e582. [Google Scholar] [CrossRef]
  37. Zhang, L.; Wang, Y. Tauroursodeoxycholic acid alleviates h(2)o(2)-induced oxidative stress and apoptosis via suppressing endoplasmic reticulum stress in neonatal rat cardiomyocytes. Dose Response 2018, 16, 1559325818782631. [Google Scholar] [CrossRef]
  38. Qiu, Y.; Cheng, R.; Liang, C.; Yao, Y.; Zhang, W.; Zhang, J.; Zhang, M.; Li, B.; Xu, C.; Zhang, R. Microrna-20b promotes cardiac hypertrophy by the inhibition of mitofusin 2-mediated inter-organelle Ca2+ cross-talk. Mol. Ther. Nucleic Acids 2020, 19, 1343–1356. [Google Scholar] [CrossRef]
  39. Santulli, G.; Xie, W.; Reiken, S.R.; Marks, A.R. Mitochondrial calcium overload is a key determinant in heart failure. Proc. Natl. Acad. Sci. USA 2015, 112, 11389–11394. [Google Scholar] [CrossRef]
  40. de Ridder, I.; Kerkhofs, M.; Lemos, F.O.; Loncke, J.; Bultynck, G.; Parys, J.B. The er-mitochondria interface, where Ca2+ and cell death meet. Cell Calcium 2023, 112, 102743. [Google Scholar] [CrossRef]
  41. Li, G.; Mongillo, M.; Chin, K.T.; Harding, H.; Ron, D.; Marks, A.R.; Tabas, I. Role of ero1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J. Cell Biol. 2009, 186, 783–792. [Google Scholar] [CrossRef] [PubMed]
  42. Tabas, I.; Ron, D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 2011, 13, 184–190. [Google Scholar] [CrossRef] [PubMed]
  43. Li, A.; Gao, M.; Liu, B.; Qin, Y.; Chen, L.; Liu, H.; Wu, H.; Gong, G. Mitochondrial autophagy: Molecular mechanisms and implications for cardiovascular disease. Cell Death Dis. 2022, 13, 444. [Google Scholar] [CrossRef] [PubMed]
  44. Wang, S.; Binder, P.; Fang, Q.; Wang, Z.; Xiao, W.; Liu, W.; Wang, X. Endoplasmic reticulum stress in the heart: Insights into mechanisms and drug targets. Br. J. Pharmacol. 2018, 175, 1293–1304. [Google Scholar] [CrossRef]
Figure 1. Dependence of the viability of H9c2 cells on the concentration of AST (10 µM), H2O2 (100 µM), and DOX (100 µM). (a) Cytotoxic effect of AST, H2O2, and AST+H2O2; (b) cytotoxic effect of AST, DOX, and AST+DOX. The proportion of living cells was determined one, four, and six hours after the addition of substances using the resazurin reduction method. The number of living cells in the intact culture (control, without drug treatment) was taken as 100%. Data are presented as the mean ± standard deviation (n = 10). * p < 0.05 indicates significant changes compared to the control (intact culture); # p < 0.05 indicates significant change compared to the corresponding values of H2O2 or DOX.
Figure 1. Dependence of the viability of H9c2 cells on the concentration of AST (10 µM), H2O2 (100 µM), and DOX (100 µM). (a) Cytotoxic effect of AST, H2O2, and AST+H2O2; (b) cytotoxic effect of AST, DOX, and AST+DOX. The proportion of living cells was determined one, four, and six hours after the addition of substances using the resazurin reduction method. The number of living cells in the intact culture (control, without drug treatment) was taken as 100%. Data are presented as the mean ± standard deviation (n = 10). * p < 0.05 indicates significant changes compared to the control (intact culture); # p < 0.05 indicates significant change compared to the corresponding values of H2O2 or DOX.
Life 14 01409 g001
Figure 2. Effect of AST and its combined action with H2O2 and DOX on the death of H9c2 cardiomyocytes. (a) Cell death in control (untreated cells), with AST, H2O2, and AST+H2O2; (b) cell death in control (untreated cells), with AST, DOX, and AST+DOX. Cells treated with 1% Triton X-100 were considered 100% dead and were taken as a positive control. Data are presented as the mean ± standard deviation (n = 8). * p < 0.05 indicates significant change compared to the control (intact culture); # p < 0.05 indicates significant changes compared to the corresponding values of H2O2 or DOX.
Figure 2. Effect of AST and its combined action with H2O2 and DOX on the death of H9c2 cardiomyocytes. (a) Cell death in control (untreated cells), with AST, H2O2, and AST+H2O2; (b) cell death in control (untreated cells), with AST, DOX, and AST+DOX. Cells treated with 1% Triton X-100 were considered 100% dead and were taken as a positive control. Data are presented as the mean ± standard deviation (n = 8). * p < 0.05 indicates significant change compared to the control (intact culture); # p < 0.05 indicates significant changes compared to the corresponding values of H2O2 or DOX.
Life 14 01409 g002
Figure 3. Effect of AST (10 μM) and H2O2 (100 μM) on the area of mitochondrial mass in H9c2 cells. (a) Mitochondria stained with MitoTracker Green FM; the cell nuclei stained with Hoechst 33342; (b) mitochondrial area calculated using the ImageJ software. The data are presented as the mean ± standard deviation (n = 5). * p < 0.05 indicates significant change compared to the control (intact culture); # p < 0.05 indicates significant changes compared to the corresponding values of H2O2.
Figure 3. Effect of AST (10 μM) and H2O2 (100 μM) on the area of mitochondrial mass in H9c2 cells. (a) Mitochondria stained with MitoTracker Green FM; the cell nuclei stained with Hoechst 33342; (b) mitochondrial area calculated using the ImageJ software. The data are presented as the mean ± standard deviation (n = 5). * p < 0.05 indicates significant change compared to the control (intact culture); # p < 0.05 indicates significant changes compared to the corresponding values of H2O2.
Life 14 01409 g003
Figure 4. Effect of AST (10 μM) and DOX (100 μM) on the area of mitochondrial mass in H9c2 cells. (a) Mitochondria stained with MitoTracker Green FM; cell nuclei stained with Hoechst 33342; (b) the mitochondrial area calculated using the software ImageJ. Data are presented as the mean ± standard deviation (n = 5). * p < 0.05 indicates a significant change compared to the control (intact culture); # p < 0.05 indicates significant changes compared to the corresponding values of DOX.
Figure 4. Effect of AST (10 μM) and DOX (100 μM) on the area of mitochondrial mass in H9c2 cells. (a) Mitochondria stained with MitoTracker Green FM; cell nuclei stained with Hoechst 33342; (b) the mitochondrial area calculated using the software ImageJ. Data are presented as the mean ± standard deviation (n = 5). * p < 0.05 indicates a significant change compared to the control (intact culture); # p < 0.05 indicates significant changes compared to the corresponding values of DOX.
Life 14 01409 g004
Figure 5. Effect of AST on the content of cytosolic Ca2+ in H9c2 cardiomyocytes during H2O2- and DOX-induced cytotoxicity. (a) the content of cytosolic Ca2+ in the presence of AST and H2O2; (b) the content of cytosolic Ca2+ in the presence of AST and DOX. Fluorescence intensity of intact cells was used as a control (without drug treatment), standardized to 2.5 × 105 cells. Data are presented as the mean fluorescence intensity ± standard deviation (n = 6). * p <0.05 significant changes compared to the corresponding control, # p <0.05 significant change compared to H2O2 or DOX.
Figure 5. Effect of AST on the content of cytosolic Ca2+ in H9c2 cardiomyocytes during H2O2- and DOX-induced cytotoxicity. (a) the content of cytosolic Ca2+ in the presence of AST and H2O2; (b) the content of cytosolic Ca2+ in the presence of AST and DOX. Fluorescence intensity of intact cells was used as a control (without drug treatment), standardized to 2.5 × 105 cells. Data are presented as the mean fluorescence intensity ± standard deviation (n = 6). * p <0.05 significant changes compared to the corresponding control, # p <0.05 significant change compared to H2O2 or DOX.
Life 14 01409 g005
Figure 6. Effect of AST on the content of VDAC1 and CHOP in H9c2 cardiomyocytes during H2O2 and DOX-induced cytotoxicity. (a) Upper part: Western blot stained by VDAC1 antibody; low part: graphs quantifying changes in the protein content normalized to GAPDH; (b)—upper part: Western blot stained by CHOP antibody; low part: graphs quantifying changes in the protein content normalized to GAPDH. Protein levels in cell lysate (without additives) served as control (100%). Data are presented as the mean ± standard deviation (n = 4), * p < 0.05 indicates significant changes compared to the control. # p < 0.05 indicates significant changes compared to H2O2 or DOX.
Figure 6. Effect of AST on the content of VDAC1 and CHOP in H9c2 cardiomyocytes during H2O2 and DOX-induced cytotoxicity. (a) Upper part: Western blot stained by VDAC1 antibody; low part: graphs quantifying changes in the protein content normalized to GAPDH; (b)—upper part: Western blot stained by CHOP antibody; low part: graphs quantifying changes in the protein content normalized to GAPDH. Protein levels in cell lysate (without additives) served as control (100%). Data are presented as the mean ± standard deviation (n = 4), * p < 0.05 indicates significant changes compared to the control. # p < 0.05 indicates significant changes compared to H2O2 or DOX.
Life 14 01409 g006
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Krestinin, R.; Kobyakova, M.; Baburina, Y.; Sotnikova, L.; Krestinina, O. Astaxanthin Protects Against H2O2- and Doxorubicin-Induced Cardiotoxicity in H9c2 Rat Myocardial Cells. Life 2024, 14, 1409. https://doi.org/10.3390/life14111409

AMA Style

Krestinin R, Kobyakova M, Baburina Y, Sotnikova L, Krestinina O. Astaxanthin Protects Against H2O2- and Doxorubicin-Induced Cardiotoxicity in H9c2 Rat Myocardial Cells. Life. 2024; 14(11):1409. https://doi.org/10.3390/life14111409

Chicago/Turabian Style

Krestinin, Roman, Margarita Kobyakova, Yulia Baburina, Linda Sotnikova, and Olga Krestinina. 2024. "Astaxanthin Protects Against H2O2- and Doxorubicin-Induced Cardiotoxicity in H9c2 Rat Myocardial Cells" Life 14, no. 11: 1409. https://doi.org/10.3390/life14111409

APA Style

Krestinin, R., Kobyakova, M., Baburina, Y., Sotnikova, L., & Krestinina, O. (2024). Astaxanthin Protects Against H2O2- and Doxorubicin-Induced Cardiotoxicity in H9c2 Rat Myocardial Cells. Life, 14(11), 1409. https://doi.org/10.3390/life14111409

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop